David Sans
Plus aucun poste en cours
Fortune : 10 347 $ au 31/03/2024
Profil
David Sans worked as the Head of Business Development at ImClone LLC and as the Chief Corporate Development at Calidi Biotherapeutics, Inc. He holds a doctorate degree from Ramon Llull University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/09/2023 | 18 314 ( 0,05% ) | 10 347 $ | 31/03/2024 |
Anciens postes connus de David Sans
| Sociétés | Poste | Fin |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Director/Board Member | - |
| CALIDI BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de David Sans
| Ramon Llull University | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CALIDI BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
